April 6, 2011 
The new report is out. I haven’t read it yet, but here’s the teaser graphic from the website.
One Response to “The 2010 Express Scripts Drug Trend Report Is Out”
Leave a Reply
Share This
My LinkedIn Profile
WSJ Health Blog
- Is a Paleo Diet Healthier Than Standard Nutritional Guidelines?
- Small Business and the Affordable Care Act: How Has Your Business Been Affected?
- HealthCare.gov Explorer: Decode the Health Law’s Subsidies
- One Reporter, Four Families, Six Scientists and the Search to Cure a Rare Disease
- Your Responses: How Has the Health Law Affected You?
- What Does the Health Law Mean for You? Your Questions Answered
- How Has the Health Law Affected You?
- Rare Diseases and the Search for a Cure: A Reddit AMA
- Robots to Cure Rare Diseases: A Reddit Ask Me Anything (AMA)
- Six Tips For Better Napping
Drug Channels
- The Drug Discount Ecosystem’s “Mission Critical”
- Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
- Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
- The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies
- PBMs and the Battle Over Patient Support Funds:Accumulators, Maximizers, and Alternative Funding (NEW Live Video Webinar)
- Four Ways for Field Teams to Tackle Drug Utilization Management and Optimize Patient Access
- Employers Expand Use of Alternative Funding Programs—But Sustainability in Doubt as Loopholes Close
- Adapt or Fall Behind: The Need for Agile Copay Programs in Today's Shifting Payer Landscape
- Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2023 Update
- The State of the Specialty Market 2023: Reflections, Trends, and Photos from #Asembia23
KevinMD Blog
- An error has occurred; the feed is probably down. Try again later.
Health Populi
- Searching for Health/Care Touchpoints in the 2023 Axios Harris Poll 100
- What $31,065 Can Buy You: a Toyota Corolla Cross Hybrid, a Year at Gnomon School, or Healthcare for a Family of 4 in America
- Band-Aid® Rules: Health is Baked Into The Most Trusted Brands in 2023 In Retail, Beauty, and Non-Profits
- The Growing Pet Economy – What It Means for Human Health, Well-Being, and Healthcare Costs
- Our Mental and Emotional Health Are Interwoven With What We Eat and Drink – Chewing On the IFIC 2023 Food and Health Survey
- Retail Clinics’ Growing Role in Health Care and Prescription Drug Sales
- Medical Debt: “The Debt of Necessity” – A Current U.S. Picture from the CFPB
- Getting Health Care at a Retail Pharmacy vs a Retail Store: Consumers May Be Favoring the Pharmacist Versus the Retailer
- Health Systems Must Move “Beyond the Walls” to Support Consumers’ Well-Being
- Three More Signposts on the Road to Retail Health – Weight Loss Drugs, OTC Birth Control and Fashion-Meets-the-Flu
e-Patients
- How Trust Fuels Equitable Health Outcomes
- The Power of the Prescription Pad
- A Reminder of How To Care Through Self-Reflection
- Glimmers of Hope: Real Progress In Participatory Medicine
- Participatory Medicine: the Final Mile of Health Care System Change
- AI Gives SPM a New Opportunity to Lead
- In hospice, Mighty Casey receives SPM’s “Doc Tom” Award
- Full scholarship or free reg for DIA Global Boston: apply by March 31
- Mighty Casey is entering hospice
- How to Increase Applications from Underrepresented Scholars for Funding Mechanisms
Enabling Healthy Decisions Blog by www.georgevanantwerp.com is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Contact Information
Contact me at gvanantwerp @ mac.com.
Enabling Healthy Decisions 
Default-enrollment with easy opt-out is the name of the game. So by default, everyone would be enrolled in step therapy, mail delivery, restrictive retail network, generic, and etc. This was a natural progression of where where things have been heading. Next stop is financial penalties. (a la retail refill allowance)
One thing I did find interesting is ESRX’s use of various data points (whatever they are) to predict non-adherence behavior and preemptively intervene. Would love to see how sophisticated their system really is on this.
All in all, good information. I however would not have used the word ‘intent’. Instead, ‘interest’ or ‘strong interest’ is more accurate description of what they were trying to convey. “Intent” implies you’ve made a mental commitment to follow through with an action, but that’s not the same as my answering “Yes” to “Would you switch to mail order to save your employer money?”
I struggled with their usage of the word intent, because it’s so prevalent throughout the report. But overall, very useful report with a lot of data points.